About – Solco Healthcare

Our history starts with Solco and Prinston’s parent company Zhejiang Huahai Pharmaceutical.  Huahai devotes itself to providing high-quality medicinal and health products around the world with the goal of improving the quality of life for all people.  Huahai is a large scale, modern pharmaceutical group that integrates formulations, active pharmaceutical ingredients (API) and intermediates, to deliver high quality generic medications throughout the world.  Founded in 1989, Huahai expanded to the United States in 2004 forming Huahai US to sell API to US pharmaceutical customers.  The company’s main therapeutic areas include generic prescription cardiovascular, central nervous system, and anti-viral products.  Huahai is considered a global leading API and finished dosage manufacturer in these areas.

Huahai is a pioneer in the China pharmaceutical industry becoming the first Chinese pharmaceutical manufacturing company to receive US FDA approval for its finished dosage product marketed in the United States.  Today, Huahai is rated as a “Green Factory” by the Ministry of Industry and Information Technology of the P.R.C., supporting its commitment to the World Environment that it proudly serves.  Huahai has two API manufacturing sites in China capable of producing 700 and 4,500 metric tons annually.  In addition, Huahai’s state-of-the-art finished dosage facility in Linhai, China is capable of producing over 20 billion tablets and capsules annually. 

In 2010, Huahai launched Prinston Pharmaceutical, a generic drug delivery company focused on developing generic prescription pharmaceutical products for the US market.  Combining Prinston’s strategic drug development capabilities with Huahai’s state of the art, high quality manufacturing capabilities created the opportunity to self-distribute its products throughout the US via the customary generic channels (i.e., wholesalers, distributors, chain stores, etc.).

In 2012, Huahai/Prinston acquired Solco Healthcare US from Legacy Pharmaceuticals.  Solco was a new generic pharmaceutical distributor, founded in 2010.   Relying on key development partners to launch its products, Solco quickly created a name for itself by offering value driven products with impeccable service and supply.  It was these key qualities and a shared vision of offering greater access to affordable medications that convinced Huahai/Prinston to acquire Solco.